Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A study to investigate the process by which ABT-126 is absorbed, distributed, metabolized and
eliminated by the body of stable schizophrenic volunteers receiving treatment with an
atypical antipsychotic.